The Biology of Bio-Replacement
The Clinical Objective Most medical implants remain "foreign bodies." Acellular Bovine Pericardium Matrices (ABPM) represent a shift: under the right conditions, they…
Read article →
Surgeon Spotlight | Restoring Femininity
It’s not often you meet a surgeon who speaks about 'magic' and 'vocation' in the same breath as 'biological matrices' and 'pre-pectoral…
Read article →
Patient-Reported Outcomes in Breast Reconstruction: Why BREAST-Q Matters
Why the patient’s own experience — measured with tools like the BREAST-Q — is increasingly the real test of reconstructive success.
Read article →
Complication Rates in Implant-Based Breast Reconstruction: What the Evidence Shows
The common complications, why reported rates vary so widely, and which levers are actually controllable.
Read article →
How to Read a Breast Reconstruction Clinical Study: Outcomes That Matter
How to judge a reconstruction study critically — design, endpoints, confounding, follow-up, and whether the evidence is product-specific.
Read article →
Xenograft vs. Allograft Biological Matrix: Origins and What They Mean
Animal-derived vs. human-derived matrices: how origin shapes consistency, supply, structure and handling in reconstruction.
Read article →
How a Biological Matrix Integrates: Revascularisation and Tissue Remodelling
Integration versus encapsulation — how the body turns a scaffold into vascularised living tissue, and why that is the property that matters…
Read article →
How Biological Matrices Are Made: Decellularisation and Sterilisation Explained
How raw tissue becomes an implantable scaffold: removing cells and contaminants while preserving the collagen the body needs to integrate.
Read article →
Types of Biological Matrices: Sources, Structure and How They Differ
Biological matrices differ by source (xenograft vs. allograft) and structure (dermal, pericardial, bilayer) — and those differences matter.
Read article →
The Breast Reconstruction Industry: Market Landscape and the Rise of Med Tech
What drives demand, where the med-tech layer of matrices and fat processing fits, and how European regulation is raising the evidence bar.
Read article →